Logo image of HQH

ABRDN HEALTHCARE INVESTORS (HQH) Stock Price, Quote, News and Overview

NYSE:HQH - New York Stock Exchange, Inc. - US87911J1034 - Currency: USD

15.66  -0.42 (-2.61%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to HQH. HQH was compared to 0 industry peers in the Unkown industry. The financial health of HQH is average, but there are quite some concerns on its profitability. HQH has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

HQH had positive earnings in the past year.
Of the past 5 years HQH 4 years were profitable.
In the past 5 years HQH always reported negative operating cash flow.
HQH Yearly Net Income VS EBIT VS OCF VS FCFHQH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

Industry RankSector Rank
ROA 17.44%
ROE 17.45%
ROIC N/A
ROA(3y)0.84%
ROA(5y)7.72%
ROE(3y)0.77%
ROE(5y)7.72%
ROIC(3y)N/A
ROIC(5y)N/A
HQH Yearly ROA, ROE, ROICHQH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

HQH's Profit Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 1717.73%
GM 1.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-11.11%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HQH Yearly Profit, Operating, Gross MarginsHQH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K 2K -2K

More info and screens

5

2. Health

2.1 Basic Checks

Compared to 1 year ago, HQH has more shares outstanding
Compared to 5 years ago, HQH has more shares outstanding
There is no outstanding debt for HQH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HQH Yearly Shares OutstandingHQH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
HQH Yearly Total Debt VS Total AssetsHQH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

HQH has an Altman-Z score of 371.34. This indicates that HQH is financially healthy and has little risk of bankruptcy at the moment.
HQH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 371.34
ROIC/WACCN/A
WACCN/A
HQH Yearly LT Debt VS Equity VS FCFHQH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.52 indicates that HQH may have some problems paying its short term obligations.
A Quick Ratio of 0.52 indicates that HQH may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.52
HQH Yearly Current Assets VS Current LiabilitesHQH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

3

3. Growth

3.1 Past

HQH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 199.16%, which is quite impressive.
HQH shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.25% yearly.
HQH shows a small growth in Revenue. In the last year, the Revenue has grown by 4.62%.
HQH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.68% yearly.
EPS 1Y (TTM)199.16%
EPS 3Y1.25%
EPS 5YN/A
EPS Q2Q%400%
Revenue 1Y (TTM)4.62%
Revenue growth 3Y19.29%
Revenue growth 5Y7.68%
Sales Q2Q%17.07%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HQH Yearly Revenue VS EstimatesHQH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 4.40, the valuation of HQH can be described as very cheap.
When comparing the Price/Earnings ratio of HQH to the average of the S&P500 Index (27.54), we can say HQH is valued rather cheaply.
Industry RankSector Rank
PE 4.4
Fwd PE N/A
HQH Price Earnings VS Forward Price EarningsHQH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HQH Per share dataHQH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

HQH has a Yearly Dividend Yield of 14.43%, which is a nice return.
HQH's Dividend Yield is rather good when compared to the S&P500 average which is at 2.35.
Industry RankSector Rank
Dividend Yield 14.43%

5.2 History

HQH has paid a dividend for at least 10 years, which is a reliable track record.
HQH has decreased its dividend recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
HQH Yearly Dividends per shareHQH Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
HQH Yearly Income VS Free CF VS DividendHQH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

More info and screens

ABRDN HEALTHCARE INVESTORS

NYSE:HQH (7/21/2025, 4:15:00 PM)

15.66

-0.42 (-2.61%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners22.08%
Inst Owner Change0%
Ins Owners0.01%
Ins Owner Change0%
Market Cap843.45M
Analysts0
Price TargetN/A
Short Float %0.09%
Short Ratio0.23
Dividend
Industry RankSector Rank
Dividend Yield 14.43%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years1
Div Non Decr Years1
Ex-Date05-22 2025-05-22 (0.54)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 4.4
Fwd PE N/A
P/S 78.31
P/FCF N/A
P/OCF N/A
P/B 0.8
P/tB 0.8
EV/EBITDA N/A
EPS(TTM)3.56
EY22.73%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.2
BVpS19.67
TBVpS19.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 17.44%
ROE 17.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1717.73%
GM 1.86%
FCFM N/A
ROA(3y)0.84%
ROA(5y)7.72%
ROE(3y)0.77%
ROE(5y)7.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-11.11%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.52
Altman-Z 371.34
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)199.16%
EPS 3Y1.25%
EPS 5YN/A
EPS Q2Q%400%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.62%
Revenue growth 3Y19.29%
Revenue growth 5Y7.68%
Sales Q2Q%17.07%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y70.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A